VindorosineCAS# 5231-60-7 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 5231-60-7 | SDF | Download SDF |
PubChem ID | 11618751 | Appearance | Powder |
Formula | C24H30N2O5 | M.Wt | 426.5 |
Type of Compound | Alkaloids | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | methyl (1R,9R,10S,11R,12R,19R)-11-acetyloxy-12-ethyl-10-hydroxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylate | ||
SMILES | CCC12C=CCN3C1C4(CC3)C(C(C2OC(=O)C)(C(=O)OC)O)N(C5=CC=CC=C45)C | ||
Standard InChIKey | SASWULSUPROHRT-MCIGMTSASA-N | ||
Standard InChI | InChI=1S/C24H30N2O5/c1-5-22-11-8-13-26-14-12-23(18(22)26)16-9-6-7-10-17(16)25(3)19(23)24(29,21(28)30-4)20(22)31-15(2)27/h6-11,18-20,29H,5,12-14H2,1-4H3/t18-,19+,20+,22+,23+,24-/m0/s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | 1. Vindorosine has blood vessel relaxation effect, possible underlying mechanisms involving the inhibition of Ca(2+) entry via L-type Ca(2+) channels in vascular smooth muscles. |
Targets | Calcium Channel | Sodium Channel |
Vindorosine Dilution Calculator
Vindorosine Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.3447 mL | 11.7233 mL | 23.4467 mL | 46.8933 mL | 58.6166 mL |
5 mM | 0.4689 mL | 2.3447 mL | 4.6893 mL | 9.3787 mL | 11.7233 mL |
10 mM | 0.2345 mL | 1.1723 mL | 2.3447 mL | 4.6893 mL | 5.8617 mL |
50 mM | 0.0469 mL | 0.2345 mL | 0.4689 mL | 0.9379 mL | 1.1723 mL |
100 mM | 0.0234 mL | 0.1172 mL | 0.2345 mL | 0.4689 mL | 0.5862 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Anisatin
Catalog No.:BCC8118
CAS No.:5230-87-5
- Flavoglaucin
Catalog No.:BCN6398
CAS No.:523-73-9
- Evolitrine
Catalog No.:BCN8350
CAS No.:523-66-0
- Angelicin
Catalog No.:BCN5669
CAS No.:523-50-2
- 4-Amino-2,5-dimethoxy-N-phenylbenzenesulphonamide
Catalog No.:BCC8676
CAS No.:52298-44-9
- Ginsenoside Rg2
Catalog No.:BCN1067
CAS No.:52286-74-5
- Ginsenoside Re
Catalog No.:BCN1073
CAS No.:52286-59-6
- Ginsenoside Rf
Catalog No.:BCN1075
CAS No.:52286-58-5
- 3,5-Diprenyl-4-hydroxybenzaldehyde
Catalog No.:BCN4624
CAS No.:52275-04-4
- CGP 57380
Catalog No.:BCC5279
CAS No.:522629-08-9
- Isomucronulatol
Catalog No.:BCN1428
CAS No.:52250-35-8
- Parathyroid hormone (1-34) (human)
Catalog No.:BCC1046
CAS No.:52232-67-4
- p,p-hydroxy-curucumin
Catalog No.:BCC8890
CAS No.:52328-96-8
- Tetramethylcurcumin
Catalog No.:BCN2746
CAS No.:52328-97-9
- Dimethylcurcumin
Catalog No.:BCN2748
CAS No.:52328-98-0
- 6alpha-Chloro-5beta-hydroxywithaferin A
Catalog No.:BCN8007
CAS No.:52329-20-1
- Alnusone
Catalog No.:BCN8108
CAS No.:52330-11-7
- 2-Benzoyl-1,3,4,4a,5,8a-hexahydro-6(2H)-isoquinolinone
Catalog No.:BCC8559
CAS No.:52346-14-2
- Erysotramidine
Catalog No.:BCN5670
CAS No.:52358-58-4
- Epistephamiersine
Catalog No.:BCN5671
CAS No.:52389-15-8
- Wedelolactone
Catalog No.:BCN5672
CAS No.:524-12-9
- gamma-Fagarine
Catalog No.:BCN5673
CAS No.:524-15-2
- Dauricine
Catalog No.:BCN4977
CAS No.:524-17-4
- Fraxin
Catalog No.:BCN1237
CAS No.:524-30-1
Antagonism of Ca2+ influx via L-type Ca2+ channels mediates the vasorelaxant effect of Catharanthus roseus-derived vindorosine in rat renal artery.[Pubmed:25340466]
Planta Med. 2014 Dec;80(18):1672-7.
Catharanthus roseus is a traditional herbal medicine used in Asian and African countries for the treatment of various diseases including hypertension. The present study examined possible cellular mechanisms for the relaxation of rat renal arteries induced by Vindorosine extracted from C. roseus. Intrarenal arteries were isolated from 200-300 g male Sprague-Dawley rats and treated with different pharmacological blockers and inhibitors for the measurement of vascular reactivity on a Multi Myograph System. Fluorescence imaging by laser scanning confocal microscopy was utilized to determine the intracellular Ca(2+) level in the vascular smooth muscles of the renal arteries. Vindorosine in micromolar concentrations relaxes renal arteries precontracted by KCl, phenylephrine, 11-dideoxy-9alpha,11alpha-epoxymethanoprostaglandin F2alpha, and serotonin. Vindorosine-induced relaxations were unaffected by endothelium denudation or by treatment with the nitric oxide synthase inhibitor N (G)-nitro-L-arginine methyl ester hydrochloride, the guanylyl cyclase inhibitor 1H-[1, 2, 4]oxadiazolo[4,3-a]quinoxalin-1-one, the cyclooxygenase inhibitor indomethacin, or K(+) channel blockers such as tetraethylammonium ions, glibenclamide, and BaCl2. Vindorosine-induced relaxations were attenuated in the presence of 0.1 microM nifedipine (an L-type Ca(2+) channel blocker). Vindorosine also concentration-dependently suppressed contractions induced by CaCl2 (0.01-5 mM) in Ca-free 60 mM KCl solution. Furthermore, fluorescence imaging using fluo-4 demonstrated that 30 min incubation with 100 microM Vindorosine reduced the 60 mM KCl-stimulated Ca(2+) influx in the smooth muscles of rat renal arteries. The present study is probably the first report of blood vessel relaxation by Vindorosine and the possible underlying mechanisms involving the inhibition of Ca(2+) entry via L-type Ca(2+) channels in vascular smooth muscles.
Asymmetric total synthesis of vindorosine, vindoline, and key vinblastine analogues.[Pubmed:20809620]
J Am Chem Soc. 2010 Sep 29;132(38):13533-44.
Concise asymmetric total syntheses of vindoline (1) and Vindorosine (2) are detailed based on a unique intramolecular [4 + 2]/[3 + 2] cycloaddition cascade of 1,3,4-oxadiazoles inspired by the natural product structures. A chiral substituent on the tether linking the dienophile and oxadiazole was used to control the facial selectivity of the initiating Diels-Alder reaction and set the absolute stereochemistry of the remaining six stereocenters in the cascade cycloadduct. This key reaction introduced three rings and four C-C bonds central to the pentacyclic ring system setting all six stereocenters and introducing essentially all the functionality found in the natural products in a single step. Implementation of the approach for the synthesis of 1 and 2 required the development of a ring expansion reaction to provide a 6-membered ring suitably functionalized for introduction of the Delta(6,7)-double bond found in the core structure of the natural products. Two unique approaches were developed that defined our use of a protected hydroxymethyl group as the substituent that controls the stereochemical course of the cycloaddition cascade. In the course of these studies, several analogues of vindoline were prepared containing deep-seated structural changes presently accessible only by total synthesis. These analogues, bearing key modifications at C6-C8, were incorporated into vinblastine analogues and used to probe the unusual importance (100-fold) and define the potential role of the vinblastine Delta(6,7)-double bond.